Cornerstone Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Cornerstone Financial Management's REGN Position: Q2 2026 in Review
Cornerstone Financial Management increased its Regeneron Pharmaceuticals (REGN) stake by 27% in Q2 2026, buying an estimated $2.04K and bringing the position to 14 shares worth $8.73K. The position accounts for 0.01% of the portfolio, ranked #502.
Cornerstone Financial Management first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Cornerstone Financial Management held 14 shares of Regeneron Pharmaceuticals worth $8.73K as of Q2 2026.
- Cornerstone Financial Management bought 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
- Regeneron Pharmaceuticals made up 0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #502 holding.
- Cornerstone Financial Management first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.